JOURNAL OF GERONTOLOGY AND GERIATRICS https://www.jgerontology-geriatrics.com/ <div class="section "><label for="description-localization-popover-container-5dc00ec6337c8">Journal summary</label> - inglese</div> <div class="section "> <div> <h2>Cos’è Lorem Ipsum?</h2> <p><strong>Lorem Ipsum</strong> è un testo segnaposto utilizzato nel settore della tipografia e della stampa. Lorem Ipsum è considerato il testo segnaposto standard sin dal sedicesimo secolo, quando un anonimo tipografo prese una cassetta di caratteri e li assemblò per preparare un testo campione. È sopravvissuto non solo a più di cinque secoli, ma anche al passaggio alla videoimpaginazione, pervenendoci sostanzialmente inalterato. Fu reso popolare, negli anni ’60, con la diffusione dei fogli di caratteri trasferibili “Letraset”, che contenevano passaggi del Lorem Ipsum, e più recentemente da software di impaginazione come Aldus PageMaker, che includeva versioni del Lorem Ipsum.</p> </div> </div> en-US <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>AUTHORSHIP STATEMENT FORM</strong></span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>The corresponding author must sign the </strong></span></span></span><a href="/libraryFiles/downloadPublic/3"><span style="color: #d71f2b;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Authorship Statement Form</strong></span></span></span></a><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>, save it in .pdf and return it by uploading at our submission platform </strong></span></span></span><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>http://www.jgerontology-geriatrics.com</strong></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify">&nbsp;</p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>It is the policy of the Journal to correspond exclusively with one designated corresponding author. As the corresponding author, it is your responsibility to communicate with your co-authors.</strong></span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify">&nbsp;</p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>AUTHORSHIP RESPONSIBILITY</strong></span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">(1) All authors participated sufficiently in the intellectual content, analysis of data (if applicable) and writing of the article, by the criteria for authorship by the International Committee of Medical Journal Editors (http://www.icmje.org/). (2) The corresponding author certifies that the definitive version of the manuscript has been approved by all co-authors, as well as, director of the Institute or Department where the work has been carried out. (3) All persons who have made substantial contributions to the work reported in this manuscript (e.g., data collection, writing or editing assistance) but who do not fulfill the authorship criteria are named along with their specific contributions as an acknowledgement in the manuscript. The corresponding author certifies that all persons named in the acknowledgement section have provided written permission to be named. (4) All authors have reviewed the final version of the article and approve it for publication. (5) Authors must state that the article submitted has previously published, and is not under consideration or accepted for publication (in whole or in part) elsewhere nor have assigned any right or interest in the article to any third party. (6) Written permission from the authors to reproduce any material copyright elsewhere has been obtained prior to submission. (7) Authors must specify that consent has been obtained from taking part in the investigations or, in the case of paediatric patients, from the guardian/s and that they have obtained written releases from patients whose names or photographs are submitted as part of the article. (8) For reports containing original corresponding author should have full access to all the data in the study and takes responsibility for the integrity of the data accuracy of data analysis. (9) Any manuscript concerned with human subjects, medical records, or human tissue that is submitted “Journal of Gerontology and Geriatrics” should comply with the principles stated in the Declaration of Helsinki “Ethical Principles Medical Research Involving ‘Human Subjects”, adopted by the 18 World Medical Assembly, Helsinki, Finland, June 1964, amended most recently by the 64 World Medical Assembly, Fontaleza, Brazil, October 2013. If the study involves human subjects or records of human patients ethical approval MUST have been obtained. The corresponding author must state ethical approval was given, by whom and the relevant Judgement</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">s reference number. The manuscript should contain a statement that the work has been approved by the appropriate Ethical Committee related to the institution(s) in which the work was and that subjects gave informed consent to the work. “Journal of Gerontology and Geriatrics” requires institutional Ethics Committee approval for all human studies. For retrospective studies on patients</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"> records either a statement of approval or a statement exemption from the Committee is required. </span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>Ref N° of the Ethical Committee Approval must be indicated in the <a href="/libraryFiles/downloadPublic/3">Authorship Statement Form</a>. The study was approved by the Institutional Ethical Committee (the Name of the Institution must indicated in the <a href="/libraryFiles/downloadPublic/3">Authorship Statement Form</a>) and this is clearly stated in the Methods section of the article.</strong></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"> This statement should also be provided upon submission of the manuscript. Studies involving experiments with animals must state that their was in accordance with institution guidelines and relevant national laws. (10) The article contains no libelous or unlawful statements,</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">does not infringe the privacy of others, or contains material or instructions that might cause harm or injury. The corresponding author shall indemnify and hold the Editors and its agents and licensees harmless from any damages, costs, and expenses reasonable attorney</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">s fees and costs of settlement) resulting by reason of any claim, action, or proceeding finally sustained settled inconsistent with the foregoing warranties and representations. (11) All manuscripts are screened for plagiarism, which</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">implies immediate rejection. Suspected plagiarism is handled in accordance with the COPE flowcharts (http://publicationethics.org/resources/flowcharts).</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">Every author or co-author of any article published in this Journal is solely responsible for the contents of the article, for the statement made in their paper and for the material sent. Every author or co-author needs to fully comply with the Regulation 2016/679 of the European Parliament and of the Council of 27 April 2016 on the protection of natural persons with regard processing of personal data and on the free movement of such data, and repealing Directive 95/46/EC (General Data Protection Regulation): “</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><em>Article 9. Processing of personal data revealing racial or ethnic origin, political opinions, religious or philosophical beliefs, or trade union membership, and the processing of genetic data, biometric data for the purpose of uniquely identifying natural person, data concerning health or data concerning a natural person's sex life or sexual orientation shall be prohibited</em></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">”.</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify">&nbsp;</p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>PRIVACY POLICY STATEMENT. </strong></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">Personal data of the author will be managed by the Publisher in full compliance with the legislation on the privacy protection (art. 13 of EU regulation 2016/6799). According to articles 15-20 of the GDPR, any author may exercise specific rights, including the right to obtain access to personal data in an intelligible form, correct, update or them. Authors will also have the right to obtain from the Publisher limitation of data processing, and may also oppose to data processing legitimate reasons. In the case that the author believes that processing of his/her own personal data infringes GDPR regulation, he/she has the right to make a complaint to the Supervisory Authority for the Protection of Personal Data to art. 77 of the GDPR. Controller of data processing, according to art. 4.1.7 of the GDPR, is Mrs. Donatella Paoletti for Pacini Srl, with registered office in 56121 Pisa, Italy, Via A Gherardesca n. 1. To exercise the rights of GDPR referred to in paragraph same article, you can address any request for information to the following e-mail: privacy@pacinieditore.it. For further information refer to the website: http://www.jgerontology-geriatrics.com/informativa-privacy-privacy-policy/</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify">&nbsp;</p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>FINANCIAL DISCLOSURE. </strong></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">All authors must state any information that may be perceived as potential conflict of interest. must disclose all their affiliations including any relevant personal or institutional financial involvement (employment by an concern, consultancies, honoraria, speakers bureau, stock ownership or options, expert testimony, grants received or pending, membership on a standing advisory council or committee, a seat on the board of directors, or being publicly associated with company or its products, royalties, donation of medical equipment, etc.) with any organization that to any author</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">s knowledge direct interest, particularly a financial interest, in the subject matter or materials discussed. This declaration will be treated Editor as confidential while the paper is under review, and will not be made known to Reviewers. Please indicate on the </span></span></span><strong><a href="/libraryFiles/downloadPublic/3"><span style="color: #d71f2b;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">Authorship</span></span></span> <span style="color: #d71f2b;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">Statement Form </span></span></span></a></strong><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">whether or not you have or may have such a conflict of interest regarding the content of this article and nature of it.</span></span></span></p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify">&nbsp;</p> <p style="margin-bottom: 0cm; line-height: 100%; orphans: 0; widows: 0;" align="justify"><a name="_GoBack"></a> <span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;"><strong>COPYRIGHT TRANSFER AGREEMENT</strong></span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">. (a) Authors assign to “Journal of Gerontology and Geriatrics”, all copyright in and to including but not limited to the right to publish, republish, transmit, sell, distribute and otherwise use the article in whole or electronic and print editions of the Journal and in derivative works throughout the world, in all languages and in all media expression now known or later developed, and to license or permit others to do so. (b) The authors retain all proprietary rights, than copyright, such as patent rights. The authors retain the right to reuse any portion of the work, without charge, in personal compilations or other publications consisting solely of the author(s</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">) own works, including the author(s</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">) personal web home and to make copies of all or part of the Work for the author(s</span></span></span><span style="color: #212529;"><span style="font-family: American Typewriter, serif;"><span style="font-size: medium;">ʼ</span></span></span><span style="color: #212529;"><span style="font-family: Times New Roman, serif;"><span style="font-size: medium;">) use for lecture or classroom purposes. The corresponding declares that any person named as co-author of the article is aware of the submission and has agreed to being so named. corresponding author accepts responsibility for releasing this material on behalf of any and all co-authors. The corresponding declares that statements and opinions given in the article are the expression of the authors. Responsibility for the content article rests upon the authors.</span></span></span></p> secretary@jgerontology-geriatrics.com (Gianluigi Vendemiale - Editor In Chief) support-jgg@pacinieditore.it (Manuela Mori, Valentina Barberi) Tue, 30 Sep 2025 08:08:10 +0000 OJS 3.1.2.4 http://blogs.law.harvard.edu/tech/rss 60 The relationship between fall anxiety and fall behaviors in geriatric patients undergoing orthopedic surgery with a history of falling https://www.jgerontology-geriatrics.com/article/view/853 <p><strong>Background</strong>. Falls in older adults pose significant health risks and have both physical and psychological effects. This condition is an important factor influencing fall anxiety and fall behaviors.<br><strong>Aim</strong>. The aim of this study is to examine the relationship between fall anxiety and fall behaviors in geriatric patients who were admitted to the orthopedic ward and underwent orthopedic surgery due to a fall.<br><strong>Method</strong>. A cross-sectional correlational study was conducted with 97 patients aged 65 and above in the orthopedic clinic of a state hospital between September 2023 and September 2024. Data were collected<br>through face-to-face surveys using the “Patient Identification Form”, the “International Falls Efficacy Scale”, and the “Fall Behaviors Scale for Older Adults”, and statistical analysis was performed.<br><strong>Results</strong>. The average age of the patients was 72.62 ± 6.52, with 55.7% being male, 76.3% married, 86.6% unemployed, and 40.2% having completed primary school. 76.3% had chronic illnesses, and 75.3% had a history of surgery. 85.6% of the patients reported fall anxiety, and 78.4% had a fall history. High levels of fall anxiety and risk were found, and demographic factors were found to be associated with these behaviors. <br><strong>Conclusions</strong>. A strong relationship between fall anxiety and fall risk was observed in older individuals. To reduce this, it is suggested to implement physical activity programs, educational interventions, environmental adjustments, and psychosocial support. Additionally, the need for multidisciplinary research is emphasized.</p> Sibel Altıntaş, Sema Şahiner, Sevim Çelik, Elif Karahan Copyright (c) 2025 JOURNAL OF GERONTOLOGY AND GERIATRICS https://www.jgerontology-geriatrics.com/article/view/853 Mon, 29 Sep 2025 13:56:15 +0000 Association of waist-calf circumference ratio with frailty by Fried Frailty Phenotype questionnaire in older adults from Japan https://www.jgerontology-geriatrics.com/article/view/826 <p><strong>Objective</strong>. The waist circumference (WC) to calf circumference (CC) ratio (WCR), a measure of visceral fat, was calculated from WC and CC, measures of abdominal obesity and skeletal muscle mass, respectively. <br>In this study, we investigated the relationship of WCR with pre-frailty and frailty using the Fried Frailty Phenotype Questionnaire (FFPQ).<br><strong>Methods</strong>. A total of 175 community-dwelling older adults in Wakasa-cho, Kaminaka-Mikata-gun, Fukui Prefecture, Japan were included in this study. Frailty was determined by the FFPQ scores, with those <br>who scored 0, 1-2, and ≥&nbsp; 3 on the FFPQ being considered robust, pre-frailty, and frailty, respectively.<br><strong>Results</strong>. Pre-frailty and frailty were diagnosed in 90 (51.4%) and 18 (10.3%) patients, respectively, using the FFPQ (p = 0.001). CC was not significantly different between the groups (p = 0.415). WCR was significantly higher in the pre-frailty and frailty groups than in the robust group (p &lt; 0.001). The FFPQ scores were significantly positively correlated with WCR (r = 0.364, p &lt; 0.001). Pre-frailty and frailty diagnosed by FFPQ were analysed in relation to WCR, WC, and CC by ordinal logistic regression analysis, which showed that WCR and CC were associated with pre-frailty and frailty after adjustment (WCR: odds ratio (OR) 5.72, 95% confidence interval (CI) 1.43-23.70, p = 0.015; CC: OR 0.81, 95% CI 0.69-0.94, p = 0.006).<br><strong>Conclusions</strong>. This study investigated the association of WCR with prefrailty and frailty diagnosed using the FFPQ in community-dwelling older adults. High abdominal fat and low lower leg muscle mass were significantly associated with frailty and WCR during the pre-frailty stage.</p> Yuki Niida, Hidenori Onishi, Ryouko Ikeda, Yasutaka Mizukami, Masafumi Kubota, Tomoko Okamoto, Hiromasa Tsubouchi, Taisei Inoue, Hiraku Watanabe, Daiki Hasegawa, Fumie Maeda, Yuya Nakajima, Kousuke Murayama, Hirohiko Ohama, Tokuharu Tanaka, Naohiro Konoshita, Masamichi Ikawa, Osamu Yamamura Copyright (c) 2025 JOURNAL OF GERONTOLOGY AND GERIATRICS https://www.jgerontology-geriatrics.com/article/view/826 Mon, 29 Sep 2025 14:22:44 +0000 A review on Klotho: FGF23 mediated pathway integration and aging https://www.jgerontology-geriatrics.com/article/view/819 <p style="line-height: 200%; margin-bottom: 0cm;" align="justify">Aging is driven by interconnected genetic, metabolic, and environmental factors that manifest as hallmarks including genomic instability, telomere attrition, epigenetic drift, and altered intercellular signaling. The Klotho-FGF23 axis has emerged as a critical regulator linking mineral metabolism to systemic aging processes. Membrane-bound Klotho, primarily in the kidney and parathyroid, acts as an obligate co-receptor for FGF23 to regulate phosphate and vitamin D homeostasis, while soluble Klotho exerts hormone-like effects that modulate Wnt, IGF-1, NF- κB, and TGF-β pathways, influencing oxidative stress, inflammation, and tissue regeneration. Deficiency of Klotho or FGF23 in animal models results in hyperphosphatemia, vascular calcification, and premature aging phenotypes, whereas Klotho overexpression or supplementation extends lifespan and enhances stress resilience. Beyond its renal role, FGF23 can activate Klotho-independent FGFR4 signaling in cardiomyocytes, promoting hypertrophy and contributing to cardiovascular risk. <br>This review integrates current mechanistic insights on Klotho-FGF23 signaling within the framework of aging hallmarks, differentiating protective Klotho-dependent pathways from maladaptive Klotho-independent effects. We evaluate therapeutic strategies including recombinant Klotho protein, gene therapy, dietary phosphate restriction, FGFR4 inhibition, and senolytics approaches that restore Klotho expression. Key translational challenges remain assay variability and poor standardization of soluble Klotho measurement, limited longitudinal human data, and differences between murine models and human aging. Addressing <br>these barriers will be essential to advancing Klotho-FGF23 targeted interventions as a viable strategy to extend health span and delay age-related pathologies.</p> Shareshtha Devi Copyright (c) 2025 JOURNAL OF GERONTOLOGY AND GERIATRICS https://www.jgerontology-geriatrics.com/article/view/819 Mon, 29 Sep 2025 14:23:27 +0000 New approaches to ending skin problems in persons with fecal incontinence: a systematic review https://www.jgerontology-geriatrics.com/article/view/855 <p><strong>Objective</strong>. To conduct a systematic review of the current literature on products used in preventing and managing skin problems in individuals diagnosed with fecal incontinence.<br><strong>Methods</strong>. The Medline Complete, Cochrane Library, Ovid, Google Scholar, PubMed, Scopus, Science Direct and Taylor &amp; Francis databases along with Ethos, Open Dissertation and Openthesis databases were used to scan the literature. The methodology for the study was structured in the PICOS format and according to the PRISMA checklist.<br><strong>Results</strong>. This systematic review included a total of 10 articles published between 2012 and 2022 that met the predefined inclusion criteria for Randomized Controlled Trials (RCTs), Quasi-Experimental Studies (QES), and Interventional Studies. Absorbent products were chosen to prevent and manage the skin problems of most of the patients. In addiction bsorbent products, creams, barrier films, barrier cloths, barrier sprays, incontinence briefs containing a spiral-shaped fiber moistened with an alkaline solution, silicone-bordered foam dressings and onepiece drainable fecal pouches were used.<br><strong>Conclusions</strong>. The investigations showed that over-hydration of the epidermis can be controlled with absorbent products, which are also effective in preventing and managing incontinence-associated dermatitis (IAD). The use of new absorbent products or increasing awareness of frequent pad changes may have a positive impact. Additionally, cleansing agents, barrier creams, films, cloths, sprays, incontinence briefs with spiral-shaped fiber moistened with alkaline solution, silicone-bordered foam dressings, and one-piece drainable fecal pouches were found to be effective.</p> Dilek Aygin, Hilal Kaynak Aydoğmuş, Cansu Kubilay, Büşra Ecem Kumru Copyright (c) 2025 JOURNAL OF GERONTOLOGY AND GERIATRICS https://www.jgerontology-geriatrics.com/article/view/855 Mon, 29 Sep 2025 14:27:17 +0000 A rare case of oral myiasis in a severely frail older patient https://www.jgerontology-geriatrics.com/article/view/862 <p><strong>Background</strong>. Myiasis, derived from the Greek “myia” (fly) and “iasis” (disease), refers to infestation by dipterous larvae. First coined by Hope in 1840 and later defined by Zumpt, myiasis involves larvae feeding on live or necrotic tissues. Oral myiasis, a rare condition first described by Laurence in 1909, typically affects individuals with compromised oral hygiene, necrotic lesions, or systemic debilitation.<br><strong>Case presentation</strong>. We report a case of oral myiasis in a 73-year-old non-ambulatory female with multiple comorbidities. The patient presented with pain and swelling in the maxillary anterior region, accompanied by severe halitosis, poor oral hygiene, and live larvae emerging from necrotic oral tissues. Clinical and entomological examination identified the larvae as <em>Chrysomya bezziana</em>. Necrotic tissue was surgically debrided, mobile teeth extracted, and the patient was followed up after anti helminthic medications. Post-operative care included oral hygiene instruction and follow-up. The patient responded well to the treatment. <br><strong>Conclusions</strong>. Oral myiasis is an uncommon yet serious condition, predominantly affecting debilitated or geriatric patients with poor oral hygiene. Awareness and early intervention are crucial for effective management. Preventive strategies such as routine oral care and regular follow-up are essential, especially in vulnerable populations.</p> Jayachandran Sadaksharam, Archana Muralidharan Copyright (c) 2025 JOURNAL OF GERONTOLOGY AND GERIATRICS https://www.jgerontology-geriatrics.com/article/view/862 Mon, 29 Sep 2025 14:33:19 +0000